fexinidazole
Selected indexed studies
- Fexinidazole: First Global Approval. (Drugs, 2019) [PMID:30635838]
- Fexinidazole. (, 2006) [PMID:39626038]
- Fexinidazole. (, 2012) [PMID:37535799]
_Worker-drafted node — pending editorial review._
Connections
fexinidazole is a side effect of
Sources
- Fexinidazole: First Global Approval. (2019) pubmed
- Fexinidazole. (2006) pubmed
- Fexinidazole. (2012) pubmed
- Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership. (2022) pubmed
- Fexinidazole for the treatment of human African trypanosomiasis. (2019) pubmed
- Fexinidazole. (2021) pubmed
- Fexinidazole induced cytotoxicity is distinct from related anti-trypanosome nitroaromatic drugs. (2023) pubmed
- Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review. (2021) pubmed
- Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: a prospective, open-label, single-arm, phase 2-3, non-randomised study. (2025) pubmed
- Human African trypanosomiasis. (2025) pubmed